Genomic imprinting is a normal process of gene regulation revealed in mammals[@R1] and flowering plants.[@R2] Genomic imprinting leads some autosomal genes to be expressed solely from the maternal inherited chromosomes, and others are expressed solely from the paternal inherited chromosomes; thus, the corresponding paternally or maternally inherited alleles, respectively, are silenced. It is a non-Mendelian epigenetic form of gene regulation that is germline-inherited, the epigenetic marks being established in the parental gametes without altering the DNA sequence. The marks are subsequently maintained after fertilization, transmitted through cell division and differentiation and read in the tissue where the parental allele should be repressed.[@R1]

Approximately 150 genes are imprinted in mouse and in humans ([www.har.mrc.ac.uk/research/genomic-imprinting/](http://www.har.mrc.ac.uk/research/genomic-imprinting/)), and the vast majority are expressed in placenta and in the brain. At the individual level, a monoallelic expression instead of a biallelic expression should be more deleterious since, when mutated, the functioning allele could not be compensated by the other allele that is silenced; this raises the question about the relevance of genomic imprinting. The reason(s) why this mechanism has been selected/maintained throughout evolution is not clear, although several hypotheses have been put forward.[@R3] Obviously, genomic imprinting imposes sexual reproduction since the functional contributions of the paternal and maternal genomes are necessary for normal embryonic and extra-embryonic development.[@R4]^-^[@R6] Post-natally, imprinted genes are mainly involved in metabolism,[@R7]^,^[@R8] energy homeostasis, and behavior[@R9] and play a role in the adaptation to early postnatal life.[@R10] A lack of expression of some of these genes is associated with pathologies in human and mouse, and a 2-fold increase in imprinted gene expression can also be found in human disorders, suggesting that expression dosage is critical for at least some imprinted genes.[@R11] In view of this, genomic imprinting should be a robust mechanism, reproducible from generation to generation and allowing (1) the monoallelic expression of those paternal or maternal developmental genes necessary for a normal development and (2) a control over gene dosage to prevent both copies being expressed.

Paradoxically to this idea of robustness, imprinting regulation is an epigenetic mechanism, and per se, flexibility of this mechanism should be observed in somatic cells. Indeed, imprinted genes have been hypothesized to be vulnerable to environmental perturbation,[@R12]^,^[@R13] leading to somatic imprinting alterations and causing several developmental diseases.[@R14] It has also been suggested that genomic imprinting allows developmental plasticity in response to environmental conditions.[@R15] However in a situation of induced maternal undernutrition, an environmental alteration, imprinted genes appear neither more susceptible to, or more protected from, expression perturbations, either in the F1 or F2 generation.[@R8] An interesting approach to study the flexibility of genomic imprinting might be analysis of genes showing tissue specific imprints (approximately 30% of all imprinted genes). The aforementioned genes show imprinted expression in one specific tissue and biallelic expression in other tissues within the same organism, suggesting that tissue-specific factors contribute to the allelic relaxation.[@R16] The study of these tissue-specific differences in allelic expression will shed new light on the relationship between epigenetic marks and the state of allelic repression.

When the active allele of an imprinted gene is mutated, loss of imprinting (LOI) might compensate for the lack of expression of this gene, allowing the expression of the corresponding silent allele. In this context, such an imprinted flexibility might be considered as a rheostat that enhances the adaptability to a changing genomic environment and might potentially contribute to the positive selection of imprinting mechanisms through mammalian evolution. Until now, few cases of reactivation of a normally silent allele rescuing an altered phenotype have been described,[@R17]^,^[@R18] but it seems important to examine other situations in which the LOI improves and/or rescues a phenotypic trait. Understanding the mechanisms underlying the robustness and/or flexibility of imprinting regulation is an important first step in finding ways to manipulate this rheostat function in health and disease.

Prader-Willi Syndrome (PWS) is the most studied neurogenetic disease involving imprinted genes (1/25000, OMIM 176270). The essential clinical criteria include neonatal hypotonia and abnormal feeding behavior with a poor suck followed by a hyperphagia, resulting in severe obesity and behavioral problems.[@R19]^-^[@R22] Breathing deficiency, with central apneas present from birth, is a significant health concern for many patients and contributes to some cases of sudden death.[@R23]^,^[@R24] Other characteristics of the syndrome include hypogonadism, severe skin picking, and abnormal pain responses. Notably, there is considerable variability in the severity of the symptoms among patients.[@R19] To date, no comprehensive physiopathological mechanisms have been clearly identified. A dysfunction of the central nervous system, in particular of the hypothalamus, has been identified in PW patients and mouse models for PWS share this dysfunction.[@R25]

From the genetic point of view, PWS is a contiguous gene syndrome resulting from the loss of expression of the paternal copies of genes located in the 15q11-q13 region; thus, PWS involves a cluster of maternally imprinted genes[@R19]---five genes code for proteins (MKRN3, MAGEL2, NECDIN, NPAP1/C15orf12, and SNURF-SNRPN), other genes code for large non-coding transcripts and orphan snoRNAS, including SNORD116. Until now, based on genomic data, a major role was suggested for the SNORD116 snoRNAs, although the role of these snoRNAs was largely debated, and recently, an important role has been attributed to the large non-coding host transcript encoding the SNORD116.[@R26] Very recently, pathogenic mutations of *MAGEL2* have been reported in four patients,[@R27] causing a classical PWS in one patient and PWS-like phenotypes in the three others; all patients presented feeding difficulties in infancy, ASD, and intellectual disability. These results underline the major role of *MAGEL2* in PWS. The high degree of conservation of the PWS imprinted cluster between mouse and human at the level of both genomic organization and imprinting status has allowed the use of mouse models. Models have been established where all the paternally expressed genes in the cluster have been inactivated, but their physiological analysis has been limited since 80% of the mutant neonates die.[@R28]^-^[@R31] Their death results from a failure to thrive reminiscent of the early problems encountered in the PWS phenotype. Recently, by modifying the genetic background, a higher degree of survival has been obtained, and the resulting adult animals recall some PW features.[@R32] Single gene knockouts have also been created in order to link a specific gene with specific aspects of the PWS phenotype,[@R25] and based on the results from different laboratories, the mouse models in which *Magel2* or *Necdin* have been inactivated, recapitulate many PW features.

Since the first human and mouse PWS candidate genes[@R33]^,^[@R34] were discovered, it has been widely accepted that only their paternal alleles are expressed, the maternal alleles being completely silenced. Consequently, all the studies of mouse models have been done using heterozygous animals deleted for the paternal allele.[@R25]

However, it should be noted that the lack of maternal expression of the PW candidate genes in humans is mainly based on the absence of their corresponding transcripts in lymphoblasts, fibroblasts, and, only in a few cases, human brain tissues of PW patients (while the exact origin of the brain structure is not known). The methods used were classical reverse transcription polymerase chain reaction or Northern blot analysis. A relaxation of imprinting in two PW patients with a deletion and two atypical PW patients with a maternal disomy have been reported;[@R35]^,^[@R36] however, both studies were again made on RNAs from patients' lymphoblasts, and these studies have not been followed up. In particular, no study has ever been done using RT-qPCR or in situ hybridization or immunohistochemistry in the brains of PW patients, in whom the maternal alleles are always present. Similarly, studies performed in mouse models of PWS, in which the whole paternal region is deleted or inactivated as in PW patients, initially reported a lack of expression of the maternally inherited genes.[@R29] Subsequently, using real quantitative PCR, an incomplete silencing of PWS genes in brains of one of the mouse models has been reported;[@R28] the other models have not been investigated concerning this question.

In a recent publication in *Plos Genetics*,[@R18] Rieusset et al. reported that the mechanism regulation imprinting at the PWS locus might be flexible in both a mouse model with an inactivated *Necdin* (*Ndn*) gene and in PW patients. The *Ndn* gene is responsible for the respiratory distress observed in *Ndn* deficient mice[@R37]^,^[@R38] and probably in PW patients.

This study reports a stochastic expression of the maternally inherited allele of the *Ndn* gene in mice where the paternal gene (*Ndn +m/-p* mice) has been inactivated. Quantification of maternal *Ndn* transcripts using RT-qPCR showed an extremely low and very variable number of transcripts that were not detectable by classical RT-PCR. Unexpectedly, immunohistochemistry using anti-Ndn antibodies confirmed that these transcripts are translated into Necdin protein, detected in around 50% of *Ndn* +m/-p mice. In contrast, no expression of the maternal allele was detected in wild-type mice suggesting that it is the absence of the paternal allele that is a prerequisite for maternal allele expression. Furthermore a comparison between *Ndn* −/− and *Ndn* +m/-p pups showed that the lethality, due to respiratory distress, is decreased 2-fold in *Ndn* +m/-p compared with *Ndn* −/−. In agreement with this decreased lethality, the surviving *Ndn* +m/-p mice present a greater than 2-fold decreased incidence of apnea in adulthood. Since these apneas in *Ndn* deficient mice have previously been correlated with a deficit in the 5HT system,[@R37] the authors searched for a correlation between the number of 5HT neurons and the number of 5HT neurons expressing Necdin in *Ndn* +m/-p mice. Indeed, at the cellular level, a positive correlation was established between the level of Necdin expression and the number of 5HT neurons. This confirms the functional importance of the extremely weak expression of the *Ndn* maternal allele. Finally, *NDN* transcripts and protein were also detected in brain tissue from human Prader-Willi patients suggesting a relaxation of imprinting.

The results presented in this article nevertheless provoke a number of key questions.

\(1\) What is the mechanism allowing such maternal expression?

Rieusset et al. proposed that expression of the maternally inherited allele occurs only in absence of an active paternal allele. In support of this hypothesis, they showed that the expression of a non-imprinted BAC transgene, with the *Ndn* promoter driving eGFP expression, is significantly higher in *Ndn−/−* and *Ndn+m/-p* mice compared with WT offspring, and eGFP expression is absent in a mouse model overexpressing *Ndn*. Furthermore, on a wild-type genetic background, either eGFP or Necdin but not both, is expressed in the cells of the same brain structure that should normally express Necdin, suggesting a mechanism of expression resulting from an allelic exclusion. Explanations for these observations might include promoter competition for transcriptional activators or a mechanism involving physical contact in *trans* between promoters, a type of counting mechanism described in X chromosome inactivation.[@R39] It has previously been reported that there is pairing between the imprinted region of 15q11-q13 in humans, but this has not yet been confirmed in the mouse syntenic region.[@R40] Recently, it has been shown that chromosome pairing in somatic cells, including imprinted regions, is associated with trans-allelic effects on gene transcription.[@R41] Altogether, these results suggest that, even in the absence of imprinting regulation of *Ndn* as is the case for the *Ndn-eGFP* BAC transgene, it appears that there is a transcriptional regulation predisposed to a monoallelic expression of *Ndn*. In this context of allelic exclusion, an imprinting mechanism dictates that the maternal allele is inactivated. Imprinted genes are functionally monoallelic in a parent of origin-specific manner. This is the first data indicating that gene dosage and parent-origin expression of the *Ndn* imprinted gene might be dissociated.

Inter- and intra-individual variation in DNA methylation at the DMRs of imprinted genes has been reported in different tissues, most importantly in the brain, and might be a source of imprinting relaxation and phenotypic variations.[@R42] In the article, the authors studied DNA methylation in a secondary DMR (42 CpGs), previously shown to be correlated with imprinted regulation of *Ndn* expression, although methylation of this DMR occurs after the blastula stage. The sodium bisulphite sequencing study did not however reveal any major changes in methylation on the *Ndn* maternal allele in *Ndn* +m/-p brains. This failure to detect modifications to methylation in a secondary DMR may be the result of using whole brain extracts in the analysis: only a few neurons express the *Ndn* maternal allele, and this escapes the global brain analysis that was performed. However, another explanation might be that the methylation profile does not change, but histone modifications allow an expression of the silent maternally inherited allele.

In the context of cellular mechanism, an important question is: does the expression from the maternal allele result from all-or-none loss of imprinting in mRNA expression in single cells as described for the PLAGL1 gene?[@R43] The all-or-none loss of imprinting of *Ndn* at the single cell level has not been demonstrated, although this model is supported by immunohistochemistry and in situ hybridization results where a restricted number of cells express the maternal allele. It would be interesting to explore this all-or-none relaxation using RT-qPCR in single cells, but this is a technically difficult experiment since we cannot identify, a priori, which cells express the *Ndn* maternal allele.

\(2\) Can this relaxation of imprinting be generalized to other PWS genes?

In the literature, using RT-qPCR, an incomplete silencing of PWS genes in brains of one of the mouse models with an imprinting mutation has been previously reported.[@R28] The maternal expression could only be detected in the absence of a functional PWS-imprinting center and is suggested to be due to a *trans* effect on the maternal allele.

Our team has also investigated a mouse model deleted for the paternal allele of *Magel2*, another imprinted candidate gene for PWS. The mouse model presents a deletion including the *Magel2* promoter, and consistent with the results obtained for *Ndn*, we detected *Magel2* transcripts by ISH in *Magel2*+m/-p mice as shown in [Figure 1](#F1){ref-type="fig"}. Unfortunately, we do not have a specific anti-Magel2 antibody, and we cannot check the presence of the Magel2 protein. Importantly, the presence of Magel2 transcripts has also been observed on brain sections from PW patients (data not shown).

![**Figure 1.** Detection of *Magel2* transcript on brain sections of *Magel2* +m/-p mice. Using a specific anti-sense probe for *Magel2* transcript[@R44] (in red), in situ hybridization was performed on coronal brain sections issued from *Magel2 +/+*, *Magel2* +m/-p, and *Magel2* −/− newborns (P0). Although no signal was detected on brain sections from *Magel2* −/− mice, an expected signal is detected in wild type mice and also in *Magel2* +m/-p mice. Scale bar: 500 µm.](rdis-1-e27228-g1){#F1}

Altogether, these data suggest that the maternally inherited alleles of PWS genes might be reactivated in pathological conditions, in absence of a fully active paternal allele. Importantly, Rieusset et al. revealed that very low levels of expression of PWS maternally silenced genes might be sufficient to alleviate or rescue specific PWS symptoms and might explain the high variability in the severity of the symptoms observed in PW patients. These results are important in a therapeutic perspective, and an understanding of the context in which the *Ndn* maternal allele might be transcribed could be an important step toward the development of a pharmacological therapy to trigger and/or increase the expression of this maternal allele in PWS patients ([Fig. 2](#F2){ref-type="fig"}).

![**Figure 2.** From a controlled epigenetic silencing to loss of silencing and reactivation of the maternal alleles of PWS genes. This scheme summarizes the quantity of transcripts produced from the maternal and paternal inherited alleles of PWS genes such as *NECDIN* (NDN) and *MAGEL2* in a normal individual (**A**), in PW patients (**B and C**), or in perspective of a pharmacological therapy (**D**). In a normal individual, chromosomal 15q11-q13 regions from both parental origins are present, and transcripts issued only from the paternal allele of PWS genes are detected (**A**). In PW patients, due to a mutation of the 15q11-q13 region, there are no "PWS transcripts" issued from the paternal active allele (**B, C, and D**). However, a stochastic partial loss of silencing of the maternal alleles, named here epigenetic flexibility, may result in the production of few maternal "PWS transcripts" detected in some patients (**C**). We postulate that chemical compounds might modify this epigenetic flexibility in PW patients, allowing an increased expression of the maternal "PWS transcripts" and consequently alleviating the PWS features (**D**).](rdis-1-e27228-g2){#F2}
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